Global IVD Contract Manufacturing Services Market valued at $4.6 billion (2021), is set to witness a growth of 4% in the upcoming 5 years
Cost savings, scalability, technology know-how, and risk mitigation offered by IVD contract manufacturers drive OEM's decision to outsource to IVD CDMOs.
Increasing Preference for Point-of-Care (POC) Testing Services Fuels the growth of IVD
Contract Manufacturing Services Market
In an
endeavor to cut result time and help patients make better-informed decisions
about their health, there is considerable demand for IVD testing to move closer
to the patient i.e. point-of-care (POC) diagnostics whether in the hospital, clinic,
physician's office, or home.
Manufacturing
of specific PoC devices presents manufacturers (OEMs) with a variety of design
and manufacturing challenges. For instance, the ability to process
high-precision components that involve reagents and fluids are the most relevant
capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs.
IVD Diagnostic Kits Demand Triggered by Covid-19 Pandemic bolsters
the IVD Contract Manufacturing Services Market
Ever since the outbreak of Covid-19, the demand for IVDs
has exploded, which in turn has fueled the demand for IVD Contract
Manufacturing Services. There are several types of SARS-CoV-2 and COVID-19
related IVDs - diagnostic tests, serology/antibody and other adaptive immune
response tests and tests for management of COVID-19 patients.
Government Support to Scale Up Production of IVD Kits
in the Wake of Covid-19 spurs the IVD Contract Manufacturing Services Market
Regulators enacted several new measures to expedite access to IVD kits. Regulators issued guidance to assist and clarify new or relaxed requirements under the emergency provisions for IVDs to help accelerate their development. Expedited approval processes for IVDs played a pivotal role in combating the Covid-19 pandemic.
Competitive Landscape Analysis: IVD Contract
Manufacturing Services Market
The global IVD Contract Manufacturing Services market is marked by the
presence of key players such as Jabil, STRATEC,
Celestica, Sanmina Gerresheimer, Phillips-Medisize, Plexus, Röchling, KMC
Systems, Cenogenics Corporation, Savyon Diagnostics, Nova Biomedical, Cone
Bioproducts, Invetech, Inc., Thermo Fisher Scientific Inc., Avioq, Inc., LRE
Medical, Coris BioConcept, Meridian Bioscience, Inc., Maxim Biomedical, Inc.,
among others.
Comments
Post a Comment